Skip to main content
. Author manuscript; available in PMC: 2022 Oct 29.
Published in final edited form as: J Med Chem. 2021 Oct 12;64(20):15313–15333. doi: 10.1021/acs.jmedchem.1c01353

Scheme 2.

Scheme 2.

Reagents and conditions: a) SOCl2, toluene, DMF, RT, 12 h. (b) (1-methylpyrrolidin-3-yl)methanamine for 17a, (1-ethylpyrrolidin-3-yl)methanamine for 17b, (1-propylpyrrolidin-3-yl)methanamine for 17c, CHCl3, TEA, 0 °C to RT, 48 h. (c) CDI/THF, RT, overnight.